0.595
price down icon0.83%   -0.005
after-market After Hours: .60 0.005 +0.84%
loading

Processa Pharmaceuticals Inc Stock (PCSA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Operating Income/Loss
13.77%
-2.8096
-2.4695 -2.1676 -2.7145 -4.1055
Income/Loss From Continuing Operations Before Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Income/Loss From Continuing Operations After Tax
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Net Income/Loss
13.37%
-2.7264
-2.4049 -2.082 -2.6126 -4.0221
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
110.16%
2.4665
-24.27 27.00 26.94 22.77
Diluted Average Shares
110.16%
2.4665
-24.27 27.00 26.94 -2.0708
Basic Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.18
Diluted Earnings Per Share
86.36%
-1.11
-8.14 -0.08 -0.10 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):